Skip to content

Clinical trials

Diabetes Mellitus trials in Spain with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Not applicable Country / region: Spain Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20081
20093
20102
20111
20121
20134
20143
20154
20162
20174
20185
20194
20203
20214
20222
20233
20248
20257
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Unknown status18
Recruiting4
Not yet recruiting3
Active, not recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Universidad Complutense de Madrid5
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina4
Basque Health Service3
Fundació Sant Joan de Déu2
Fundació d'investigació Sanitària de les Illes Balears2
Institut d'Investigacions Biomèdiques August Pi i Sunyer2
Medtronic MiniMed, Inc.2
Universidad Miguel Hernandez de Elche2
Universidad de Granada2
Andalusian School of Public Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus64
Diabetes Mellitus, Type 213
Hypertension13
Obesity10
Diabetic Foot7
Metabolic Syndrome6
Cardiovascular Diseases5
Prediabetic State5
Pulmonary Disease, Chronic Obstructive5
Heart Failure4

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.